vs
Maplebear Inc.(CART)与德康医疗(DXCM)财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是Maplebear Inc.的1.3倍($1.3B vs $992.0M),德康医疗净利率更高(21.2% vs 8.2%,领先13.1%),德康医疗同比增速更快(21.6% vs 12.3%),过去两年德康医疗的营收复合增速更高(12.0% vs 10.0%)
Maplebear Inc. 以Instacart为品牌开展业务,是总部位于美国旧金山的零售媒体及配送企业,在美国和加拿大运营生鲜杂货配送与自提服务。用户可通过官网及移动应用从合作商户订购食品杂货,在法律允许的地区还可选购酒类商品,所有订单由专属采购专员负责拣选、打包并配送上门。
德康医疗是美国跨国医疗保健企业,专注于研发、生产及销售糖尿病管理领域的连续血糖监测(CGM)系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥,生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
CART vs DXCM — 直观对比
营收规模更大
DXCM
是对方的1.3倍
$992.0M
营收增速更快
DXCM
高出9.2%
12.3%
净利率更高
DXCM
高出13.1%
8.2%
两年增速更快
DXCM
近两年复合增速
10.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $992.0M | $1.3B |
| 净利润 | $81.0M | $267.3M |
| 毛利率 | 72.3% | 62.9% |
| 营业利润率 | 9.9% | 25.6% |
| 净利率 | 8.2% | 21.2% |
| 营收同比 | 12.3% | 21.6% |
| 净利润同比 | -45.3% | 153.6% |
| 每股收益(稀释后) | $0.31 | $0.67 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CART
DXCM
| Q1 26 | — | $1.3B | ||
| Q4 25 | $992.0M | $1.3B | ||
| Q3 25 | $939.0M | $1.2B | ||
| Q2 25 | $914.0M | $1.2B | ||
| Q1 25 | $897.0M | $1.0B | ||
| Q4 24 | $883.0M | $1.1B | ||
| Q3 24 | $852.0M | $994.2M | ||
| Q2 24 | $823.0M | $1.0B |
净利润
CART
DXCM
| Q1 26 | — | $267.3M | ||
| Q4 25 | $81.0M | $267.3M | ||
| Q3 25 | $144.0M | $283.8M | ||
| Q2 25 | $116.0M | $179.8M | ||
| Q1 25 | $106.0M | $105.4M | ||
| Q4 24 | $148.0M | $151.7M | ||
| Q3 24 | $118.0M | $134.6M | ||
| Q2 24 | $61.0M | $143.5M |
毛利率
CART
DXCM
| Q1 26 | — | 62.9% | ||
| Q4 25 | 72.3% | 62.9% | ||
| Q3 25 | 73.7% | 60.5% | ||
| Q2 25 | 74.2% | 59.5% | ||
| Q1 25 | 74.8% | 56.9% | ||
| Q4 24 | 75.2% | 58.9% | ||
| Q3 24 | 75.2% | 59.7% | ||
| Q2 24 | 75.7% | 62.4% |
营业利润率
CART
DXCM
| Q1 26 | — | 25.6% | ||
| Q4 25 | 9.9% | 25.6% | ||
| Q3 25 | 17.7% | 20.1% | ||
| Q2 25 | 13.6% | 18.4% | ||
| Q1 25 | 12.3% | 12.9% | ||
| Q4 24 | 17.6% | 17.0% | ||
| Q3 24 | 16.2% | 15.3% | ||
| Q2 24 | 6.3% | 15.7% |
净利率
CART
DXCM
| Q1 26 | — | 21.2% | ||
| Q4 25 | 8.2% | 21.2% | ||
| Q3 25 | 15.3% | 23.5% | ||
| Q2 25 | 12.7% | 15.5% | ||
| Q1 25 | 11.8% | 10.2% | ||
| Q4 24 | 16.8% | 13.6% | ||
| Q3 24 | 13.8% | 13.5% | ||
| Q2 24 | 7.4% | 14.3% |
每股收益(稀释后)
CART
DXCM
| Q1 26 | — | $0.67 | ||
| Q4 25 | $0.31 | $0.67 | ||
| Q3 25 | $0.51 | $0.70 | ||
| Q2 25 | $0.41 | $0.45 | ||
| Q1 25 | $0.37 | $0.27 | ||
| Q4 24 | $0.53 | $0.37 | ||
| Q3 24 | $0.42 | $0.34 | ||
| Q2 24 | $0.20 | $0.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $687.0M | $917.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.5B | $2.7B |
| 总资产 | $3.7B | $6.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CART
DXCM
| Q1 26 | — | $917.7M | ||
| Q4 25 | $687.0M | $917.7M | ||
| Q3 25 | $1.7B | $1.8B | ||
| Q2 25 | $1.6B | $1.2B | ||
| Q1 25 | $1.6B | $904.9M | ||
| Q4 24 | $1.4B | $606.1M | ||
| Q3 24 | $1.3B | $621.2M | ||
| Q2 24 | $1.4B | $939.2M |
股东权益
CART
DXCM
| Q1 26 | — | $2.7B | ||
| Q4 25 | $2.5B | $2.7B | ||
| Q3 25 | $3.5B | $2.7B | ||
| Q2 25 | $3.3B | $2.6B | ||
| Q1 25 | $3.2B | $2.3B | ||
| Q4 24 | $3.1B | $2.1B | ||
| Q3 24 | $2.9B | $2.0B | ||
| Q2 24 | $3.0B | $2.4B |
总资产
CART
DXCM
| Q1 26 | — | $6.3B | ||
| Q4 25 | $3.7B | $6.3B | ||
| Q3 25 | $4.5B | $7.5B | ||
| Q2 25 | $4.4B | $7.3B | ||
| Q1 25 | $4.3B | $6.8B | ||
| Q4 24 | $4.1B | $6.5B | ||
| Q3 24 | $3.9B | $6.4B | ||
| Q2 24 | $4.0B | $6.8B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $183.0M | — |
| 自由现金流经营现金流 - 资本支出 | $171.0M | — |
| 自由现金流率自由现金流/营收 | 17.2% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | 2.26× | — |
| 过去12个月自由现金流最近4个季度 | $910.0M | — |
8季度趋势,按日历期对齐
经营现金流
CART
DXCM
| Q1 26 | — | — | ||
| Q4 25 | $183.0M | $294.0M | ||
| Q3 25 | $287.0M | $659.9M | ||
| Q2 25 | $203.0M | $303.0M | ||
| Q1 25 | $298.0M | $183.8M | ||
| Q4 24 | $153.0M | $301.4M | ||
| Q3 24 | $185.0M | $199.5M | ||
| Q2 24 | $244.0M | $279.4M |
自由现金流
CART
DXCM
| Q1 26 | — | — | ||
| Q4 25 | $171.0M | $192.1M | ||
| Q3 25 | $272.0M | $579.4M | ||
| Q2 25 | $187.0M | $208.9M | ||
| Q1 25 | $280.0M | $96.8M | ||
| Q4 24 | $141.0M | $176.8M | ||
| Q3 24 | $171.0M | $88.3M | ||
| Q2 24 | $220.0M | $213.3M |
自由现金流率
CART
DXCM
| Q1 26 | — | — | ||
| Q4 25 | 17.2% | 15.3% | ||
| Q3 25 | 29.0% | 47.9% | ||
| Q2 25 | 20.5% | 18.1% | ||
| Q1 25 | 31.2% | 9.3% | ||
| Q4 24 | 16.0% | 15.9% | ||
| Q3 24 | 20.1% | 8.9% | ||
| Q2 24 | 26.7% | 21.2% |
资本支出强度
CART
DXCM
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 8.1% | ||
| Q3 25 | 1.6% | 6.7% | ||
| Q2 25 | 1.8% | 8.1% | ||
| Q1 25 | 2.0% | 8.4% | ||
| Q4 24 | 1.4% | 11.2% | ||
| Q3 24 | 1.6% | 11.2% | ||
| Q2 24 | 2.9% | 6.6% |
现金转化率
CART
DXCM
| Q1 26 | — | — | ||
| Q4 25 | 2.26× | 1.10× | ||
| Q3 25 | 1.99× | 2.33× | ||
| Q2 25 | 1.75× | 1.69× | ||
| Q1 25 | 2.81× | 1.74× | ||
| Q4 24 | 1.03× | 1.99× | ||
| Q3 24 | 1.57× | 1.48× | ||
| Q2 24 | 4.00× | 1.95× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CART
| Transaction | $698.0M | 70% |
| Advertising And Other | $294.0M | 30% |
DXCM
暂无分部数据